| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 27.78M | — |
| Operating expense | — | — |
| Net income | -1.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALGS returned -33.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -26.9% |
| 1 year | -33.2% |
| 5 years | -98.4% |
| All-time high | $718.50 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ALGS would be worth today ›No. Aligos Therapeutics, Inc. has not paid a dividend in the past 12 months.
Aligos Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ALGS.
Aligos Therapeutics, Inc. is part of the Healthcare sector.
Aligos Therapeutics, Inc. has a market cap of 42.53M USD, based on the latest quote.
Aligos Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
